Could a simple salt swap lower blood pressure in kidney transplant patients?
NCT ID NCT07178964
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether using a potassium-enriched salt substitute (75% regular salt, 25% potassium chloride) instead of regular table salt can help control blood pressure in kidney transplant recipients. About 80 participants will use either the special salt or regular salt at home for 12 weeks. The main goal is to see if blood pressure improves without causing dangerously high potassium levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
potassium-enriched salt substitute (25% potassium chloride, 75% sodium chloride)
What this could lead to
If it works, this could offer a simple dietary swap to help kidney transplant patients better control their blood pressure without extra medication.
What could go wrong
This is a small, early-stage trial with only 80 participants, so results may not apply broadly. There is a risk of dangerously high potassium levels (hyperkalemia) in some patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact